Medical Research Law & Policy Report® Index-Summary

RADIOACTIVE MATERIAL

– Classification system, possible NRC revisions, 178
– Countermeasures for exposure, 558
– Nuclear waste, interstate disposal compact between Ala. and N.C. (U.S., oral arg), 54; no liability for N.C., 377; equitable claims, 525
– Ohio rules proposed, 525; issued, 661

RESEARCH AND DEVELOPMENT (R&D)

– Access to federally-funded research, House roundtable, 48; open access debate, 482
– Akron as biomaterials innovation hub, 492
– Alzheimer's funding sought, 142
– Antibacterial drugs, FDA guidance, 370
– Antimicrobial drugs, FDA guidance, 560
– Archived publication access, federally-funded research, 23
– Biomedical research

– – Funding decline, 47
– – NIST standards, 133
– – Policy framework urged, 586
– – Social science and biospecimens, 456

– Brain damage study in newborns (D. Mass.), 608
– Budget, federal science priorities, 487
– Canada digital archive of published health research, 283
– Cancer

– – Capps research proposal, 207
– – Plagiarism and falsifying research, no federal jurisdiction (E.D. Pa.), 29
– – Tex. Cancer Prevention and Research Inst., 26; rules, 148
– – Univ. of Pittsburgh prostate cancer research dispute (W.D. Pa.), 12

– Cleveland as high-tech hub, 381
– Clinical and Translational Science Awards from NIH, 453
– Conflicts of interest rules, development of drugs affected, 689
– Contract research organizations, 690
– Coordination by NIH and FDA, grants, 134; public comment, 369
– Data sharing by FDA and CMS, 611
– Dual use research, 411
– EU research needs, 24
– Federal patient-centered research board, 614
– Funding

– – Election 2010, Special Report, 765
– – Fla., Jackson Labs research facility, 286
– – Health reform, effect on funding, 259
– – Jobs, effect of research funding, 374
– – NIH budget

See NATIONAL INSTITUTES OF HEALTH (NIH)

– – Ontario research funding, 282
– – Recovery Act spending

– – – Construction grants, HHS IG report, 633
– – – GAO report, 632

– – Research!America forum, 756
– – Stimulus funding, report, 75

– Health IT funding, HHS awards, 21
– Hepatitis C, FDA draft guidance, 587
– HITECH Act and drug research, 532
– Human subject protection

See HUMAN SUBJECT PROTECTION

– Implantable defibrillators, AHRQ and American College of Cardiology, 112
– Improving new drug development process, 248
– Johns Hopkins cellular proteins pact (Del. Ch.), 11
– Life sciences reports from Natl. Academies Press, 658
– Malaria treatment propriety data, 343
– Medicalized weapons, ethics issues, 78
– Minority subject enrollment, 251
– Misconduct in research

– – Anesthesiologist, pain drug data fabrication admission (D. Mass.), 56; guilty plea, 150; sentenced, 415
– – Australian panel, 255
– – Autism link to vaccines, U.K. MDs guilty, 85; Lancet retraction, 116; MDs struck from register, 350
– – Bogus papers in scientific journals, 756
– – Cancer, plagiarism and falsifying research, no federal jurisdiction (E.D. Pa.), 29
– – Changed FDA procedures, IRB role, Special Report, 155
– – Cost of probes, 567
– – Data falsification, proposed rule, 138
– – Debarment by HHS, no injunction (D.D.C.), 383
– – Defamation claim by medical student against Univ. of Miami (S.D. Fla.), 107
– – Duke cancer researcher resignation, 763
– – Harvard biologist, 565
– – Integrity studies, HHS grants, 145
– – Paxil clinical trial records (E.D. La.), 589
– – Retraction sought by Mayo Clinic, 384
– – Univ. of Medicine & Dentistry grant application (D.N.J.), 696

– Modern drug design theories questioned, 656
– Natl. Toxicology Program, 692
– Offsetting costs with tax credits and incentives, BNA Insights, 505
– Outlook 2010, 5
– Paperwork burden, 785
– Physician-investigator duties, 659
– Portland State Univ., Or. biotech funding, 114
– Pregnancy and drugs, FDA collaboration with private researchers, 22
– Public disclosures and drug development, BNA Insights, 767
– Qualification of drug development tools, 691
– R&D tax credit

– – Extension

See LEGISLATION, FEDERAL, HR 4213, S 1203

– – Flexibility at Obama administration, 143
– – GOP senators seek improvements, 144

– St. Louis Univ., new medical research center, 113; ex-Pfizer staff, 148
– Stem cell research

See STEM CELL RESEARCH

– Stimulus funding and medical research, report, 139
– Stroke research, BNA Insights, 534
– Traditional business model criticized, 517
– Transition to treatment

See LEGISLATION, FEDERAL, S 914

– Translational medicine center at NIH, 786
– Translational research, FDA promotion, 94
– U.S. global leadership in medical innovation, 410
– Women

– – HIV studies, women underrepresented, 621
– – Progress in research, 621

RUSSIA

– Clinical trials

– – Accreditation, 585
– – Health insurance requirement, 625

– Medicines circulation law signed, 250